Free AHC calculators and tools Run your own numbers before your visit
Next week, July 23-24, the FDA's Pharmacy Compounding Advisory Committee will review seven peptides being considered for inclusion on the 503A Bulks List: BPC-157, KPV, TB-500, MOTS-c, DSIP, Semax, and Epitalon
A phase 3 evaluation of cAMP signaling biased GLP-1 analog ecnoglutide (XW003) in adults with type 2 diabetes
Here is another thing I saw that Healthspan is arguing: Lower and more stable glucose levels can reduce glycation, a process where sugar molecules damage proteins, lipids, and nucleic acids, potentially causing aging-related damage
I lost weight quickly on a GLP1 will the defense blame weight loss instead of the drug